192 related articles for article (PubMed ID: 24670518)
1. Type IV collagen α1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo.
Sudhakar YA; Verma RK; Pawar SC
Sci Rep; 2014 Mar; 4():4136. PubMed ID: 24670518
[TBL] [Abstract][Full Text] [Related]
2. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
[TBL] [Abstract][Full Text] [Related]
3. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.
Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A
Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256
[TBL] [Abstract][Full Text] [Related]
4. FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1.
Boosani CS; Nalabothula N; Munugalavadla V; Cosgrove D; Keshamoun VG; Sheibani N; Sudhakar A
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4567-75. PubMed ID: 19443723
[TBL] [Abstract][Full Text] [Related]
5. Tetrastatin, the NC1 domain of the α4(IV) collagen chain: a novel potent anti-tumor matrikine.
Brassart-Pasco S; Sénéchal K; Thevenard J; Ramont L; Devy J; Di Stefano L; Dupont-Deshorgue A; Brézillon S; Feru J; Jazeron JF; Diebold MD; Ricard-Blum S; Maquart FX; Monboisse JC
PLoS One; 2012; 7(4):e29587. PubMed ID: 22539938
[TBL] [Abstract][Full Text] [Related]
6. Selective binding of integrins from different renal cell types to the NC1 domain of alpha3 and alpha1 chains of type IV collagen.
Aggeli AS; Kitsiou PV; Tzinia AK; Boutaud A; Hudson BG; Tsilibary EC
J Nephrol; 2009; 22(1):130-6. PubMed ID: 19229828
[TBL] [Abstract][Full Text] [Related]
7. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.
Pozzi A; Moberg PE; Miles LA; Wagner S; Soloway P; Gardner HA
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2202-7. PubMed ID: 10681423
[TBL] [Abstract][Full Text] [Related]
8. Cloning, purification, and characterization of a non-collagenous anti-angiogenic protein domain from human alpha1 type IV collagen expressed in Sf9 cells.
Boosani CS; Sudhakar A
Protein Expr Purif; 2006 Oct; 49(2):211-8. PubMed ID: 16631378
[TBL] [Abstract][Full Text] [Related]
9. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.
Verma RK; Gunda V; Pawar SC; Sudhakar YA
PLoS One; 2013; 8(12):e80555. PubMed ID: 24324608
[TBL] [Abstract][Full Text] [Related]
10. Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo.
Roth JM; Akalu A; Zelmanovich A; Policarpio D; Ng B; MacDonald S; Formenti S; Liebes L; Brooks PC
Am J Pathol; 2005 Mar; 166(3):901-11. PubMed ID: 15743801
[TBL] [Abstract][Full Text] [Related]
11. MT2-MMP-dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis.
Rebustini IT; Myers C; Lassiter KS; Surmak A; Szabova L; Holmbeck K; Pedchenko V; Hudson BG; Hoffman MP
Dev Cell; 2009 Oct; 17(4):482-93. PubMed ID: 19853562
[TBL] [Abstract][Full Text] [Related]
12. Effects of collagen IV on neuroblastoma cell matrix-related functions.
Tzinia AK; Kitsiou PV; Talamagas AA; Georgopoulos A; Tsilibary EC
Exp Cell Res; 2002 Apr; 274(2):169-77. PubMed ID: 11900477
[TBL] [Abstract][Full Text] [Related]
13. Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis.
Pozzi A; LeVine WF; Gardner HA
Oncogene; 2002 Jan; 21(2):272-81. PubMed ID: 11803470
[TBL] [Abstract][Full Text] [Related]
14. T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
Wang F; Dong X; Xiu P; Zhong J; Wei H; Xu Z; Li T; Liu F; Sun X; Li J
Oncol Rep; 2015 Feb; 33(2):675-84. PubMed ID: 25483829
[TBL] [Abstract][Full Text] [Related]
15. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.
Chen X; Su Y; Fingleton B; Acuff H; Matrisian LM; Zent R; Pozzi A
Clin Exp Metastasis; 2005; 22(2):185-93. PubMed ID: 16086239
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.
Gunda V; Verma RK; Sudhakar YA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7828-35. PubMed ID: 24194191
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor.
Nyberg P; Xie L; Sugimoto H; Colorado P; Sund M; Holthaus K; Sudhakar A; Salo T; Kalluri R
Exp Cell Res; 2008 Nov; 314(18):3292-305. PubMed ID: 18775695
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice.
Miyoshi T; Hirohata S; Ogawa H; Doi M; Obika M; Yonezawa T; Sado Y; Kusachi S; Kyo S; Kondo S; Shiratori Y; Hudson BG; Ninomiya Y
FASEB J; 2006 Sep; 20(11):1904-6. PubMed ID: 16877525
[TBL] [Abstract][Full Text] [Related]
19. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth.
Ramont L; Brassart-Pasco S; Thevenard J; Deshorgue A; Venteo L; Laronze JY; Pluot M; Monboisse JC; Maquart FX
Mol Cancer Ther; 2007 Feb; 6(2):506-14. PubMed ID: 17308049
[TBL] [Abstract][Full Text] [Related]
20. Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation.
Ispanovic E; Serio D; Haas TL
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C600-10. PubMed ID: 18562481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
